Kalaris Therapeutics (KLRS) Share-based Compensation (2019 - 2026)
Kalaris Therapeutics (KLRS) reported Share-based Compensation of $644,000 for Q2 2026, up 9.0% from $591,000 a year earlier and up 11.0% from the prior quarter.
Powered by 
Analysis
Kalaris Therapeutics (KLRS) Share-based Compensation (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Kalaris Therapeutics' Share-based Compensation came in at $2.2 million, up 45.7% year-over-year; for FY2025, it came in at $1.94 million, up 116.3% from FY2024.
- Share-based Compensation has a five-year compound annual growth rate of -27.1% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $895,000 in FY2024 (-97.8%), $40.78 million in FY2023 (-1.3%), $41.32 million in FY2022 (-6.0%) and $43.98 million in FY2021 (+366.4%).
- The Q2 2026 figure ranks as the highest quarterly Share-based Compensation since Q4 2023.
- Year over year, Share-based Compensation has now increased in each of the last five quarters, with growth averaging 16.5% over the last seven quarters.
- The high point for year-over-year Share-based Compensation in five years was Q4 2021 (growth of 257.9%); the low point was Q1 2024 (a decline of 99.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $580,000 (Q1 2026), $333,000 (Q4 2025) and $638,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Kalaris Therapeutics | 67.84 Mn | 67.84 Mn | - | 644,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 644,000.00 |
| Mar 31, 2026 | 580,000.00 |
| Dec 31, 2025 | 333,000.00 |
| Sep 30, 2025 | 638,000.00 |
| Jun 30, 2025 | 591,000.00 |
| Mar 31, 2025 | 374,000.00 |
| Dec 31, 2024 | 280,000.00 |
| Sep 30, 2024 | 262,000.00 |
| Jun 30, 2024 | 322,000.00 |
| Mar 31, 2024 | 31,000.00 |
| Dec 31, 2023 | 9.99 Mn |
| Sep 30, 2023 | 10.47 Mn |
| Jun 30, 2023 | 10.29 Mn |
| Mar 31, 2023 | 10.03 Mn |
| Dec 31, 2022 | 9.04 Mn |
| Sep 30, 2022 | 10.86 Mn |
| Jun 30, 2022 | 10.95 Mn |
| Mar 31, 2022 | 10.47 Mn |
| Dec 31, 2021 | 15.86 Mn |
| Sep 30, 2021 | 10.29 Mn |
API Access
Kalaris Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=KLRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "KLRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=KLRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();